ArticleBiomedicines2025

Efficacy and Safety of the Combination of Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: A Real-World Retrospective Cohort Study.

Eishin Kurihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.